Nancy Choon‐Si Ng

Glucagon-Like Peptide-1 Receptor Agonists and Neovascular Age-Related Macular Degeneration in Type 2 Diabetes: A Review of Emerging Clinical Evidence

Abstract Purpose of Review Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used in the management of type 2 diabetes mellitus (T2DM) because of their established glycaemic, weight, cardiovascular, and kidney benefits. Recent observational evidence has raised...